ArticleOncotarget2018

Mechanisms for mTORC1 activation and synergistic induction of apoptosis by ruxolitinib and BH3 mimetics or autophagy inhibitors in JAK2-V617F-expressing leukemic cells including newly established PVTL-2.

Shinya Ishida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.